highperformr logo

Bristol's Overview

Total employees607
HeadquartersLawrenceville
Founded

Bristol Myers Squibb (BMS) is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. They focus on therapeutic areas such as oncology, immunology, cardiovascular, hematology, and neuroscience. BMS combines the agility of biotech with the reach and resources of a major pharma company, striving to make a significant impact on patients' lives worldwide through scientific innovation and a commitment to quality and safety.

Where is Bristol's Headquarters?

HQ Function

Serves as the central hub for global operations, research and development leadership, strategic planning, and corporate functions for Bristol Myers Squibb.

Notable Features:

The Princeton Pike campus is a state-of-the-art facility featuring modern research laboratories, collaborative workspaces, and employee amenities. It's designed with sustainability in mind, often incorporating green spaces and energy-efficient technologies. The campus facilitates cutting-edge scientific research.

Work Culture:

Bristol Myers Squibb fosters a work culture focused on innovation, collaboration, patient-centricity, and inclusion. Employees are encouraged to pursue scientific excellence and work cross-functionally to achieve breakthroughs in medicine. There is a strong emphasis on employee development, integrity, and passion for their mission.

HQ Significance:

The headquarters is critical as it drives the company's global strategy in tackling serious diseases. It's a key center for BMS's research efforts, global business operations, and corporate decision-making, impacting healthcare outcomes worldwide.

Values Reflected in HQ: The headquarters' design, operations, and focus on cutting-edge research reflect BMS's core values: innovation, passion, urgency, accountability, integrity, and inclusion. The facilities are built to foster collaboration and scientific discovery.

Location:

Bristol Myers Squibb maintains a significant global presence, supporting functions worldwide. These include extensive research and development operations, a network of advanced manufacturing and supply sites, and robust commercial operations (sales, marketing, market access). Additionally, medical affairs, regulatory affairs, and corporate support functions are distributed globally. The company has operations in North America, South America, Europe, Asia, and Australia, with offices and facilities designed to discover, develop, and deliver innovative medicines to patients in numerous countries around the world.

Street Address:

3401 Princeton Pike

City:

Lawrenceville

State/Province:

New Jersey

Country:

USA

Bristol's Global Presence

Uxbridge, United Kingdom

Address: Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH, UK

Key operational center for managing and expanding Bristol Myers Squibb's presence and product portfolio in the United Kingdom, contributing to European market strategies and patient access.

Devens, Massachusetts, USA

Address: 38 Jackson Rd, Devens, MA 01434, USA

Supports the global supply chain for Bristol Myers Squibb's biologic drugs, ensuring high-quality manufacturing capabilities in North America and contributing to both clinical trial supply and commercial product availability.

Tokyo, Japan

Address: Shinjuku I-Land Tower, 6-5-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo 163-1328, Japan

Drives Bristol Myers Squibb's commercial success and research initiatives in Japan, adapting global strategies to local healthcare needs, patient populations, and regulatory environments to deliver innovative medicines.

Boudry, Switzerland

Address: Route de Perreux 1, 2017 Boudry, Switzerland

Ensures reliable production and supply of key medicines for European and other international markets, adhering to stringent quality and regulatory standards. Also involved in packaging and distribution.

Buying Intent Signals for Bristol

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Bristol

As of April 2025, Bristol' leadership includes:

Christopher Boerner, Ph.D. - Chair of the Board and Chief Executive Officer
David Elkins - Executive Vice President and Chief Financial Officer
Samit Hirawat, M.D. - Executive Vice President, Chief Medical Officer, Global Drug Development
Elizabeth Mily - Executive Vice President, Strategy & Business Development
Adam Lenkowsky - Executive Vice President, Chief Commercialization Officer
Karin Shanahan - Executive Vice President, Global Product Development and Supply
Sandra Leung - Executive Vice President and General Counsel
Ann Powell - Executive Vice President, Chief Human Resources Officer
Greg Meyers - Executive Vice President, Chief Digital and Technology Officer

Investors of Bristol

Bristol has been backed by several prominent investors over the years, including:

The Vanguard Group, Inc.
BlackRock, Inc.
State Street Corporation
Wellington Management Company LLP
Capital World Investors
JP Morgan Chase & Co.
Geode Capital Management, LLC
Fidelity Management & Research Company LLC (FMR Co. LLC)

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits1

The most significant executive change at Bristol Myers Squibb in the last 12 months (from mid-2023 to mid-2024) was the planned CEO transition. Christopher Boerner, Ph.D., succeeded Giovanni Caforio, M.D., as Chief Executive Officer in November 2023. Boerner was subsequently also appointed Chair of the Board in April 2024. Other executive team adjustments have been primarily internal promotions or role realignments rather than high-profile external hires or departures at the EVP level.

Departures

Giovanni Caforio, M.D., Giovanni Caforio stepped down as CEO as part of a planned leadership succession. He continued in a transitional role as Executive Chairman and then Chair of the Board.

New Appointments:

Christopher Boerner, Ph.D., Christopher Boerner was appointed Chief Executive Officer, having previously served as Chief Operating Officer and other senior roles. He was later appointed Chair of the Board in April 2024.

Technology (Tech Stack) used by Bristol

Discover the tools Bristol uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Bristol Email Formats and Examples

Bristol Myers Squibb primarily uses the 'first.last@bms.com' email format for its employees. This is a common and standard format for large corporations, facilitating professional communication.

first.last@bms.com

Format

jane.doe@bms.com

Example

92%

Success rate

News and media

BMS Press ReleaseMay 22, 2024

Bristol Myers Squibb: U.S. FDA Accepts for Priority Review Application for Subcutaneous Nivolumab

The U.S. Food and Drug Administration (FDA) accepted Bristol Myers Squibb’s Biologics License Application (BLA) for subcutaneous nivolumab co-formulated with Halozyme’s rHuPH20 for priority review across several approved adult solid tumor indications for Opdivo (nivolumab) intravenous....more

BMS Press ReleaseApril 25, 2024

Bristol Myers Squibb Reports First Quarter Financial Results for 2024

Bristol Myers Squibb announced first quarter 2024 revenues of $11.9 billion, a 5% increase year-over-year, driven by strong performance of new products. The company also provided updates on its pipeline and strategic cost reduction initiatives....more

BMS Press ReleaseFebruary 5, 2024

Bristol Myers Squibb Successfully Completes Acquisition of RayzeBio, Inc.

Bristol Myers Squibb announced the successful completion of its acquisition of RayzeBio, Inc., a clinical-stage radiopharmaceutical therapeutics company. This acquisition aims to strengthen BMS's oncology portfolio with innovative actinium-based radiotherapies....more

BMS Press ReleaseNovember 1, 2023

Bristol Myers Squibb: Christopher Boerner Succeeds Giovanni Caforio as CEO

Christopher Boerner, Ph.D., officially assumed the role of Chief Executive Officer of Bristol Myers Squibb, succeeding Giovanni Caforio, M.D., who transitioned to Executive Chairman as part of a planned leadership succession announced earlier in the year....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Bristol, are just a search away.